HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jun Qian Selected Research

glycyl- arginyl- glycyl- aspartyl- seryl- proline

3/2008Experimental study on transarterial administration of GRGDSP combined with transarterial chemoembolization in rats with hepatic carcinoma.
4/2006[Transarterial administration of GRGDSP combined with chemoembolization for treating hepatic carcinoma in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jun Qian Research Topics

Disease

76Neoplasms (Cancer)
10/2015 - 03/2002
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2015 - 12/2005
11Carcinoma (Carcinomatosis)
08/2015 - 03/2006
10Hematologic Neoplasms (Hematological Malignancy)
12/2014 - 10/2002
9Neoplasm Metastasis (Metastasis)
08/2015 - 11/2005
9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2014 - 08/2004
8Infection
01/2014 - 01/2009
7Glioma (Gliomas)
12/2015 - 07/2012
7Lung Neoplasms (Lung Cancer)
09/2015 - 04/2010
7Myocardial Infarction
08/2015 - 07/2004
6Breast Neoplasms (Breast Cancer)
08/2015 - 03/2011
6Colorectal Neoplasms (Colorectal Cancer)
12/2013 - 09/2009
6Leukemia
10/2012 - 12/2004
5Chromosome Aberrations (Chromosome Abnormalities)
06/2013 - 06/2002
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2011 - 12/2005
4Multiple Myeloma
01/2015 - 10/2009
4Wounds and Injuries (Trauma)
10/2014 - 10/2004
4Glioblastoma (Glioblastoma Multiforme)
03/2013 - 08/2011
4Hepatocellular Carcinoma (Hepatoma)
02/2013 - 01/2003
3Reperfusion Injury
12/2015 - 10/2004
3Melanoma (Melanoma, Malignant)
11/2015 - 04/2010
3Heart Failure
11/2015 - 12/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2015 - 07/2014
3Asthma (Bronchial Asthma)
08/2015 - 03/2007
3Inflammation
08/2015 - 07/2011
3Brain Neoplasms (Brain Tumor)
07/2015 - 07/2011
3Fibrosis (Cirrhosis)
06/2015 - 02/2007
3Thrombocytopenia (Thrombopenia)
10/2014 - 08/2004
3Residual Neoplasm
02/2014 - 02/2005
3Necrosis
05/2013 - 08/2011
3Colonic Neoplasms (Colon Cancer)
03/2012 - 07/2005
2Body Weight (Weight, Body)
11/2015 - 10/2010
2Hemorrhage
08/2015 - 08/2013
2Anoxia (Hypoxia)
01/2015 - 10/2010
2Congenital Abnormalities (Deformity)
07/2014 - 07/2013

Drug/Important Bio-Agent (IBA)

11MicroRNAs (MicroRNA)IBA
05/2014 - 08/2011
8Messenger RNA (mRNA)IBA
01/2014 - 10/2004
6AntigensIBA
08/2014 - 12/2004
5Interferon Type IIBA
01/2014 - 01/2012
4Phosphotransferases (Kinase)IBA
06/2015 - 06/2010
4Glutathione PeroxidaseIBA
01/2015 - 01/2015
4GTP Phosphohydrolases (GTPases)IBA
06/2014 - 01/2010
4Carbon MonoxideIBA
06/2012 - 10/2002
4Complementary DNA (cDNA)IBA
10/2011 - 08/2004
4Transferrin (beta 2 Transferrin)IBA
03/2010 - 03/2007
3CytokinesIBA
12/2015 - 01/2014
3InterferonsIBA
08/2015 - 02/2005
3Small Interfering RNA (siRNA)IBA
01/2015 - 03/2012
3CarbonIBA
09/2014 - 09/2013
3Formaldehyde (Formol)FDA Link
05/2014 - 01/2014
3ParaffinIBA
05/2014 - 01/2014
3Proteins (Proteins, Gene)IBA
01/2014 - 12/2010
3Arginine (L-Arginine)FDA Link
01/2014 - 09/2011
3Hemoglobins (Hemoglobin)IBA
06/2013 - 01/2010
310-hydroxycamptothecinIBA
01/2013 - 10/2010
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2012 - 06/2010
3RNA (Ribonucleic Acid)IBA
01/2012 - 08/2004
3Ethanol (Ethyl Alcohol)IBA
12/2011 - 07/2010
3Iodized OilIBA
11/2011 - 11/2005
3GoldIBA
07/2011 - 02/2010
3Focal Adhesion Protein-Tyrosine KinasesIBA
06/2011 - 01/2010
3Silicon Dioxide (Sand)FDA LinkGeneric
02/2010 - 11/2008
2CreatinineIBA
11/2015 - 03/2008
2Glutamine (L-Glutamine)FDA Link
10/2015 - 02/2013
2FRZB proteinIBA
07/2015 - 01/2014
2Glucose (Dextrose)FDA LinkGeneric
02/2015 - 09/2009
2SiliconIBA
01/2015 - 01/2015
2GTPase-Activating Proteins (GTPase-Activating Protein)IBA
01/2015 - 03/2013
2Carrier Proteins (Binding Protein)IBA
07/2014 - 01/2014
2Paclitaxel (Taxol)FDA LinkGeneric
06/2014 - 06/2012
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
04/2013 - 04/2010
2Tyrosine (L-Tyrosine)FDA Link
03/2013 - 06/2012
2Glycoproteins (Glycoprotein)IBA
01/2013 - 10/2004
2Biological Markers (Surrogate Marker)IBA
01/2013 - 03/2008
2docetaxel (Taxotere)FDA Link
09/2012 - 07/2012
2LigandsIBA
07/2012 - 06/2007
2Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2012 - 09/2011
2PolyethyleneimineIBA
06/2012 - 08/2011
2Aspartic Acid (Aspartate)FDA Link
06/2012 - 09/2011
2Ethylene Glycol (Monoethylene Glycol)IBA
06/2012 - 08/2011
2poly(ethylene glycol)-co-poly(ethyleneimine)IBA
06/2012 - 08/2011
2cyclic arginine-glycine-aspartic acid peptideIBA
06/2012 - 08/2011
2protoporphyrin IXIBA
06/2012 - 01/2009
2ormosilIBA
06/2012 - 11/2008
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2012 - 07/2011
2Protein Isoforms (Isoforms)IBA
11/2011 - 11/2008
2CCAAT-Enhancer-Binding ProteinsIBA
07/2011 - 12/2005

Therapy/Procedure

9Drug Therapy (Chemotherapy)
10/2014 - 12/2004
5Lasers (Laser)
01/2015 - 01/2005
3Induced Hyperthermia (Thermotherapy)
12/2011 - 01/2005
3Transplantation (Transplant Recipients)
04/2011 - 07/2004
2Nanospheres
12/2015 - 05/2014
2Heterologous Transplantation (Xenotransplantation)
10/2015 - 07/2005
2Denervation
10/2015 - 05/2013
2Immunotherapy
09/2015 - 07/2015
2Adjuvant Chemotherapy
10/2014 - 05/2013
2Laminectomy
07/2014 - 07/2013
2Radiotherapy
02/2014 - 05/2013
2Transplants (Transplant)
09/2011 - 11/2010
2Amputation
05/2011 - 01/2009